The key COVID-19 findings in sports medicine, distilled into a clear, readable brief. The evidence is here whenever you want to go deeper.
INSIDE THIS MONITOR
30cited sources
4available findings
Study findings updated
AI-assisted evidence summary. For general information. These findings are not individual medical advice or a clinician endorsement.
THE SHORT VERSION
What’s worth knowing.
The key findings, what they mean, and the context that matters.
THE HEADLINE TAKEAWAY
Prolonged recovery beyond 90 days was reported in young competitive athletes
A study of SARS-CoV-2 cardiac involvement among young competitive athletes reported prolonged recovery lasting >90 days.
The recovery definition and the percentage's denominator are not available in this summary. The reported duration does not establish how often prolonged recovery occurred.
See the evidence
Prolonged Recovery (>90 days)
8.3% 95% CI: 5.1-12.4%
Moulson N, Petek BJ, Drezner JA, et al. SARS-CoV-2 Cardiac Involvement in Young Competitive Athletes. Circulation. 2021;144(4):256-266.
Most screened collegiate athletes returned safely to sport
99.2%
In prospective surveillance of COVID-19 cardiac involvement among collegiate athletes, 99.2% were reported to return safely to sport following a protocol with proper cardiac screening.
The result is descriptive. Safe return and its timeframe are not defined in the available summary, so this does not establish that screening caused the outcome.
See the evidence
Safe return to sport following protocol
99.2%
Daniels CJ, Rajapakse N, Engel DA, et al. Prospective Surveillance of COVID-19 Cardiac Involvement in Collegiate Athletes: A Major Heart Study. JAMA Cardiology. 2021;6(12):1369-1377.
COVID-19 studies reported acute and persistent exercise limitation
One study reported an acute decline in an exercise-capacity measure linked to COVID-19; another reported persistent exertional intolerance after COVID-19.
For the acute exercise-capacity result, neither the population nor the reference group or baseline is identified in this summary. For persistent intolerance, the population and what the percentage measures are undefined.
See the evidence
VO2max Reduction (Acute)
-10.3% 95% CI: -7.1 to -13.5%
Baratto C, Caravita S, Faini A, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. Journal of Applied Physiology. 2021;130(5):1470-1478.
Singh I, Joseph P, Heerdt PM, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161(1):54-63.
Study-specific findings. Different populations, treatments and follow-up periods can produce different results.
THE RESEARCH, AS IT ARRIVES
Latest studies.
The newest findings added to this collection. The learning from each, already distilled.
Study summaries are not available in this collection yet. The original evidence remains accessible in each monitor.
Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.
WHEN YOU WANT TO GO DEEPERSee all 4 findingsOriginal results, comparisons and study details.
4 of 4 source groupsFindings stay together with their study.
SOURCE 011 finding
Daniels CJ, Rajapakse N, Engel DA, et al. Prospective Surveillance of COVID-19 Cardiac Involvement in Collegiate Athletes: A Major Heart Study. JAMA Cardiology. 2021;6(12):1369-1377.
Baratto C, Caravita S, Faini A, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. Journal of Applied Physiology. 2021;130(5):1470-1478.
Singh I, Joseph P, Heerdt PM, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161(1):54-63.
Browse the 30 original sourcesThe complete bibliography behind this monitor.
[1]
Daniels CJ, Rajapakse N, Engel DA, et al. Prospective Surveillance of COVID-19 Cardiac Involvement in Collegiate Athletes: A Major Heart Study. JAMA Cardiology. 2021;6(12):1369-1377.
Martinez MW, Tucker AM, Bloom OJ, et al. Prevalence of Inflammatory Heart Disease Among Professional Athletes with Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening. JAMA Cardiology. 2021;6(7):745-752.
Clark DE, Parikh A, Dendy JM, et al. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR). Circulation. 2021;143(6):609-612.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiology. 2020;5(11):1265-1273.
Baratto C, Caravita S, Faini A, et al. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. Journal of Applied Physiology. 2021;130(5):1470-1478.
Rinaldo RF, Mondoni M, Parazzini EM, et al. Detraining-like effects in COVID-19 survivors: a pilot study. European Journal of Clinical Investigation. 2021;51(10):e13588.
Singh I, Joseph P, Heerdt PM, et al. Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2022;161(1):54-63.
Skjorten I, Ankerstjerne OAW, Trebinjac D, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. European Respiratory Journal. 2021;58(2):2100996.
Kim JH, Levine BD, Phelan D, et al. Coronavirus Disease 2019 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return to Play. JAMA Cardiology. 2021;6(2):219-227.
Phelan D, Kim JH, Elliott MD, et al. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expert Consensus Statement. JACC: Cardiovascular Imaging. 2020;13(12):2635-2652.
Drezner JA, Petek BJ, Grunseich K, et al. Expert Consensus Statement: Cardiovascular Considerations in Competitive Athletes During the COVID-19 Pandemic. British Journal of Sports Medicine. 2021;55(11):587-592.
Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults. Journal of the American College of Cardiology. 2022;79(17):1717-1756.
Cassar MP, Tunnicliffe EM, Petousi N, et al. Symptom Persistence Despite Improvement in Cardiopulmonary Health: Insights from longitudinal CMR, CPET, and plasma biomarkers 12 months after COVID-19. EClinicalMedicine. 2021;41:101159.
Durstenfeld MS, Sun K, Tahir P, et al. Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis. JAMA Network Open. 2022;5(10):e2236057.
Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel. New England Journal of Medicine. 2021;385(23):2140-2149.
Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine. 2022;28(2):410-422.
Wilson MG, Hull JH, Rogers J, et al. Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. British Journal of Sports Medicine. 2020;54(19):1157-1161.
Elliott N, Martin R, Heron N, et al. Infographic: Graduated return to play guidance following COVID-19 infection. British Journal of Sports Medicine. 2020;54(19):1174-1175.
Baggish AL, Ackerman MJ, Putukian M, et al. Exercise and Sports Cardiology. Section on Cardiovascular Sequelae of COVID-19. Circulation. 2020;142(24):e375-e379.
Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities. Journal of the American College of Cardiology. 2015;66(21):2362-2371.
Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of Sudden Cardiac Death in National Collegiate Athletic Association Athletes. Circulation. 2011;123(15):1594-1600.
Granillo E, Moulson N, Petek BJ, Drezner JA. Follow-up cardiac magnetic resonance imaging in athletes recovering from COVID-19. Sports Medicine. 2022;52(3):571-580.
This is an AI-assisted evidence summary, not a clinician endorsement. Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results.
Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed. Personal health and treatment decisions belong in a conversation with a qualified clinician.